Follow us for updates
© 2022 reportr.world
Read the Story →

How to Spot Fake Alaxan, Diatabs, Common Medicines, According to FDA

Some red flags are easy to spot..
by Pia Regalado
Just now
Photo/s: Shutterstock
Shares

The Food and Drug Administration on Thursday warned the public against buying counterfeit versions of popular painkillers and anti-diarrheals, citing their harmful effects.

Six over-the-counter medicines, which includes pain reliever Alaxan, antacid Kremil-S, and anti-diarrheal medicines Diatabs and Imodium, are among those flagged to have fake versions in the market.

READHow to Spot Fake Bioflu, Diatabs

The public was also reminded to buy medicine only from FDA-licensed establishments to ensure quality and safety.

Here's the difference between authentic and counterfeit medicines, according to each product:

Alaxan

The capsule, knurling or ridge patterns along the surface, security marks, and print appearance are not comparable with the standard features of the registered product.

FDA Philippines/Facebook
ADVERTISEMENT - CONTINUE READING BELOW ↓

Medicol

The capsule, knurling, security marks, and print appearance are not comparable with the standard features of the registered product.

FDA Philippines/Facebook

Buscopan

The appearance is not consistent with the original.

FDA Philippines/Facebook
ADVERTISEMENT - CONTINUE READING BELOW ↓
Recommended Videos

Kremil-S

The knurling and print appearance are not comparable with the standard features of the registered product.

FDA Philippines/Facebook

Diatabs

The knurling, security marks, and print appearance are not comparable with the standard features of the registered product.

FDA Philippines/Facebook
ADVERTISEMENT - CONTINUE READING BELOW ↓

Imodium

The blister pattern and embossed batch details are not comparable with the standard features of the registered product.

FDA Philippines/Facebook

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.